Header Logo

Connection

SANDRA GRIMM to Bevacizumab

Back to Details
This is a "connection" page, showing publications SANDRA GRIMM has written about Bevacizumab.
SANDRA GRIMM
Connection Strength
0.128
Bevacizumab
  1. A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients. J Neurooncol. 2016 Jan; 126(1):185-192.
    View in: PubMed
    Score: 0.128
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.